Silo Pharma Inc. (SILO) Emerging Leader as Psychedelics ‘on the Cusp of Entering Mainstream Psychiatry’
Mainstream acceptance of psychedelics took a “significant leap forward” with study results published in “Nature Medicine” Many say it is…
Mainstream acceptance of psychedelics took a “significant leap forward” with study results published in “Nature Medicine” Many say it is…
TravelAdvisor survey shows demand for travel remains high with majority of respondents likely to travel this year Survey also reports…
CNS Pharmaceuticals is a clinical stage biotechnology company focused on the development of novel treatments for brain tumors The company’s…
Hero Technologies (OTC: HENC) has made key acquisitions and investments that have played an essential role in its strategic business…
Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), a growing company strengthening its end-to-end supply chain production of nutritious foods…
Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the beginning of the first phase of its epilepsy research program, EPIL-A21-1. “The…
Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) has so far set base in Michigan, Florida, California, and Illinois, in…
Correlate Infrastructure Partners (OTCQB: CIPI) is leading the charge toward creating an industry-leading energy solution and financing platform for the…
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health…
LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning…